We first evaluated BRD4 expression using immunohistochemical (IHC) staining in tissue arrays containing HCC tumors and corresponding adjacent non-neoplastic liver tissues from 72 patients. The gene discussed is BRD4; the disease is hepatocellular carcinoma.